Guobang Pharma Ltd (605507) — Cash Flow Quality Index
Guobang Pharma Ltd (605507) has a Cash Flow Quality Index of 1.45x as of September 2025. Operating cash flow of CN¥311.27 Million exceeds net income of CN¥214.67 Million, indicating high earnings quality where cash backs reported profits. Explore Guobang Pharma Ltd (605507) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guobang Pharma Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Guobang Pharma Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Guobang Pharma Ltd operating cash flow efficiency.
Annual Cash Flow Quality Index for Guobang Pharma Ltd (2017–2025)
Year-by-year earnings quality comparison for Guobang Pharma Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | CN¥559.28 Million | CN¥820.82 Million | ▼ -24.7% |
| 2024 | 0.90x | CN¥706.41 Million | CN¥780.58 Million | ▲ +7.3% |
| 2023 | 0.84x | CN¥516.76 Million | CN¥612.46 Million | ▼ -23.6% |
| 2022 | 1.10x | CN¥1.02 Billion | CN¥920.62 Million | ▲ +542.8% |
| 2021 | -0.25x | CN¥-176.18 Million | CN¥706.23 Million | ▼ -126.3% |
| 2020 | 0.95x | CN¥767.70 Million | CN¥810.29 Million | ▲ +6.2% |
| 2019 | 0.89x | CN¥440.86 Million | CN¥494.01 Million | ▼ -20.4% |
| 2018 | 1.12x | CN¥541.68 Million | CN¥483.46 Million | ▲ +196.1% |
| 2017 | 0.38x | CN¥148.03 Million | CN¥391.25 Million | — |